Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402.

Source:http://linkedlifedata.com/resource/pubmed/id/19968288

J. Med. Chem. 2010 Jan 28 53 2 798-810

Download in:

View as

General Info

PMID
19968288